Stockscreener 앱 받기
338.98
2.03%
6.73
시간 외 거래:
338.98
전일 마감가:
$332.25
열려 있는:
$330
하루 거래량:
2.05M
Relative Volume:
1.27
시가총액:
$75.33B
수익:
$199.13B
순이익/손실:
$5.66B
주가수익비율:
13.50
EPS:
25.1089
순현금흐름:
$3.17B
1주 성능:
-1.96%
1개월 성능:
-8.72%
6개월 성능:
+22.69%
1년 성능:
-13.19%
1일 변동 폭
$327.83
$339.17
1주일 범위
$327.83
$347.22
52주 변동 폭
$273.71
$458.73
엘리번스 헬스 Stock (ELV) Company Profile
명칭
Elevance Health Inc
전화
(800) 331-1476
주소
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV vs UNH, CVS, CI, HUM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
338.98 | 73.84B | 199.13B | 5.66B | 3.17B | 25.11 |
|
UNH
Unitedhealth Group Inc
|
276.65 | 243.26B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
78.35 | 96.90B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
CI
Cigna Group
|
292.05 | 74.96B | 216.66B | 6.25B | 7.44B | 22.19 |
|
HUM
Humana Inc
|
193.94 | 23.28B | 126.36B | 1.30B | 1.55B | 10.67 |
엘리번스 헬스 Stock (ELV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-03 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-08 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-12-19 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-10-14 | 개시 | Goldman | Neutral |
| 2025-07-21 | 다운그레이드 | Argus | Buy → Hold |
| 2025-07-18 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-04-15 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | 업그레이드 | Argus | Hold → Buy |
| 2025-01-22 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | 다운그레이드 | Argus | Buy → Hold |
| 2024-07-18 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-06-24 | 개시 | Morgan Stanley | Overweight |
| 2024-05-30 | 개시 | Robert W. Baird | Outperform |
| 2024-03-06 | 개시 | Barclays | Overweight |
| 2023-07-12 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-03-28 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-08-22 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
모두보기
엘리번스 헬스 주식(ELV)의 최신 뉴스
Decoding Elevance Health Inc (ELV): A Strategic SWOT Insight - GuruFocus
Elevance Health, Inc. SEC 10-K Report - TradingView
Elevance Health, Inc. (ELV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - accessnewswire.com
Elevance Fights Nurses' '11th Hour' Class Expansion - Law360
Molina retreats from Medicare Advantage after forecast miss - Modern Healthcare News
Johnson Fistel, PLLP Begins Investigation on Behalf of - GlobeNewswire
Elevance Health seeks more than $1M in breach of contract lawsuit against former execs - Inside INdiana Business
Insurance companies are fining hospitals for out-of-network care. A new bill aims to stop it - WFYI
Elevance Health sues former executives for more than $1M - Indianapolis Business Journal
Elevance Health seeks more than $1M in breach of contract lawsuit against former executives - The Indiana Lawyer
Jones Financial Companies Lllp Boosts Holdings in Elevance Health, Inc. $ELV - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elevance Health, Inc. (ELV) and Encourages Stockholders to Learn More About the Investigation - accessnewswire.com
5 Revealing Analyst Questions From Elevance Health's Q4 Earnings Call - Finviz
5 Revealing Analyst Questions From Elevance Health’s Q4 Earnings Call - Yahoo Finance
This Week's Healthcare Earnings: Novo, Elevance And More - Law360
Agree To Buy Elevance Health At $165, Earn 3% Using Options - Nasdaq
Guggenheim Adjusts Elevance Health Price Target to $414 From $398, Maintains Buy Rating - marketscreener.com
Elevance Health (NYSE:ELV) Cut to "Sector Perform" at Royal Bank Of Canada - MarketBeat
RBC Downgrades Elevance Health to Sector Perform From Outperform, Cuts Price Target to $358 From $392 - marketscreener.com
Principal Financial Group Inc. Has $83.83 Million Holdings in Elevance Health, Inc. $ELV - MarketBeat
Earnings call transcript: Elevance Health Q4 2025 beats EPS forecast - Investing.com
Earnings call transcript: Elevance Health Q4 2025 beats EPS forecast By Investing.com - Investing.com India
Elevance Health, Inc. (ELV) Stock Analysis: Understanding The 12.82% Potential Upside - DirectorsTalk Interviews
Elevance Health: It Has Been Painful, But This Too Shall Pass (ELV) - Seeking Alpha
JP Morgan Raises Price Target on Elevance Health (ELV) | ELV Sto - GuruFocus
Is the Options Market Predicting a Spike in Elevance Health Stock? - TradingView
JPMorgan Chase & Co. Boosts Elevance Health (NYSE:ELV) Price Target to $397.00 - MarketBeat
Elevance Health (NYSE:ELV) Price Target Cut to $390.00 by Analysts at Truist Financial - MarketBeat
Elevance Health Shares Face Pressure Amid Cautious 2026 Guidance - AD HOC NEWS
Veritas Asset Management LLP Has $291.75 Million Stake in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health, Inc. $ELV Position Lifted by Mawer Investment Management Ltd. - MarketBeat
Elevance Health, Inc.'s (NYSE:ELV) Stock Has Fared Decently: Is the Market Following Strong Financials? - 富途牛牛
Elevance Health, Inc. $ELV Stock Holdings Lowered by Yacktman Asset Management LP - MarketBeat
National Pension Service Grows Stock Position in Elevance Health, Inc. $ELV - MarketBeat
AlphaQuest LLC Purchases New Position in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health targets at least $25.50 adjusted EPS for 2026 as company signals margin recovery and portfolio repositioning - MSN
Jefferies Financial Group Has Lowered Expectations for Elevance Health (NYSE:ELV) Stock Price - MarketBeat
Sanford C. Bernstein Has Lowered Expectations for Elevance Health (NYSE:ELV) Stock Price - MarketBeat
Barclays Adjusts Elevance Health (ELV) PT to $393 While Maintaining Overweight Rating - Finviz
Barclays adjusts Elevance Health (ELV) PT to $393 while maintaining overweight rating - MSN
Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.72 - Yahoo Finance
Elevance Health (NYSE:ELV) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
Elevance Health Earnings Call Flags Reset Before Rebound - TipRanks
Elevance Health Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Elevance Health (ELV): Wells Fargo Lowers Price Target, Maintains Overweight Rating | ELV Stock News - GuruFocus
Elevance Health (NYSE:ELV) Price Target Raised to $357.00 - MarketBeat
Wells Fargo Adjusts Price Target on Elevance Health to $391 From $424, Maintains Overweight Rating - marketscreener.com
Jefferies Adjusts Price Target on Elevance Health to $395 From $401, Maintains Buy Rating - marketscreener.com
Y Intercept Hong Kong Ltd Cuts Stock Holdings in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health, Inc. $ELV Shares Bought by New York State Common Retirement Fund - MarketBeat
Truist Financial Corp Reduces Position in Elevance Health, Inc. $ELV - MarketBeat
엘리번스 헬스 (ELV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.64%
3.66%
자본화:
|
볼륨(24시간):